Financials
Financial year 2025
AMD Pathology from Herent, company number BE0802720233, closed financial year 2025 with a result of € 211,988 after tax. For that financial year AMD Pathology recorded a gross margin of € 279,524 and equity of € 218,580. Compared with financial year 2024, the result moved from € 116,324 to € 211,988. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ 218,580
▲ 109% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 211,988
▲ 82% vs 2024
Profit after tax over the fiscal year.
€ 169,490
▲ 119% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 98,000 paid out
46 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 9,604
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,280
▼ 65% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,471
▲ € 25,578 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -16,246 | € 148,544 | € 279,524 | ▲ 88% |
| Profit after taxes | € -17,732 | € 116,324 | € 211,988 | ▲ 82% |
| Equity | € -11,732 | € 104,592 | € 218,580 | ▲ 109% |
| Total debts | € 16,117 | € 14,868 | € 51,351 | ▲ 245% |
| Cash | € 1,537 | € 77,493 | € 169,490 | ▲ 119% |
| Retained profit | € -17,732 | € 98,592 | € 212,580 | ▲ 116% |
| Dividend | € 0 | € 0 | € 98,000 | |
| Balance sheet total | € 4,386 | € 119,460 | € 269,932 | ▲ 126% |
Key figures of AMD Pathology, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about AMD Pathology the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to AMD Pathology?
What happened at AMD Pathology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 211,988 (▲ 82% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Haacht. KBO
- Anne-Marie Delsupehe became a director. NBB
In short
From € 17,732 loss in 2023 to € 211,988 profit in 2025.
Paid € 95,893 in corporate taxes since 2023.
Best year ever: 2025, with € 211,988 profit.
Paid out € 98,000 in dividends to the owners in total.
Management
Behind AMD Pathology is Anne-Marie Delsupehe.
Directors
According to the 2025 annual accounts
Anne-Marie Delsupehe
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Marcel Vanbellingenstraat 4
3020 Herent
Dennenweg 9
3150 Haacht
Active since 14 June 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DELSUPEHE Anne-Marie Elisabeth Koenraad(oprichter) 100%
Details
- Company number
- 0802.720.233
- VAT number
- BE 0802.720.233
- Registered office
- Marcel Vanbellingenstraat 4, 3020 Herent
- Names & denominations
- AMD Pathology
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 June 2023
- Peppol
- Active · Active since 2 Oct 2024